https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-03-14 / J Transl Med 2007 Mar;5:16
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-03-14 / J Transl Med 2007 Mar;5:162007-03-14 00:00:002007-03-14 00:00:00Specific targeting of whole lymphoma cells to dendritic cells ex vivo provides a potent antitumor vaccine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-02-01 / Leuk. Lymphoma 2007 Feb;48(2):302-10
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-02-01 / Leuk. Lymphoma 2007 Feb;48(2):302-102007-02-01 00:00:002019-02-15 08:48:42Generation of functional dendritic cells (DC) in adult acute lymphoblastic leukemia: rationale for a DC-based vaccination program for patients in complete hematological remission
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2007-01-01 / Free Radic. Res. 2007 Jan;41(1):73-81
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2007-01-01 / Free Radic. Res. 2007 Jan;41(1):73-812007-01-01 00:00:002007-01-01 00:00:00Gene expression in enhanced apoptosis of human lymphoma U937 cells treated with the combination of different free radical generators and hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-10-01 / Curr Drug Targets 2006 Oct;7(10):1371-4
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-10-01 / Curr Drug Targets 2006 Oct;7(10):1371-42006-10-01 00:00:002019-02-15 08:51:26Current status of immunotherapy in B cell malignancies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-05-24 / Biomed. Pharmacother. 2006 Jun;60(5):227-32
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-05-24 / Biomed. Pharmacother. 2006 Jun;60(5):227-322006-05-24 00:00:002006-05-24 00:00:00Analysis of cell proliferation and cell death during in situ hyperthermic treatment of neoplastic cells: a case report of human non-Hodgkin lymphoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-04-18 / Blood 2006 Aug;108(4):1298-305
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-04-18 / Blood 2006 Aug;108(4):1298-3052006-04-18 00:00:002019-02-15 09:25:36Antigen targeting to endosomal pathway in dendritic cell vaccination activates regulatory T cells and attenuates tumor immunity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-04-01 / Leuk. Lymphoma 2006 Apr;47(4):675-82
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-04-01 / Leuk. Lymphoma 2006 Apr;47(4):675-822006-04-01 00:00:002006-04-01 00:00:00Autologous dendritic cells pulsed with eluted peptide as immunotherapy for advanced B-cell malignancies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2006-03-07 / Ann. Hematol. 2006 May;85(5):308-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2006-03-07 / Ann. Hematol. 2006 May;85(5):308-142006-03-07 00:00:002019-02-15 09:25:36Peripheral blood mobilization of different lymphocyte and dendritic cell subsets with the use of intermediate doses of G-CSF in patients with non-Hodgkin’s lymphoma and multiple myeloma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-12-15 / Clin. Cancer Res. 2005 Dec;11(24 Pt 1):8808-15
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-12-15 / Clin. Cancer Res. 2005 Dec;11(24 Pt 1):8808-152005-12-15 00:00:002019-02-15 09:25:39Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-12-15 / Clin. Cancer Res. 2005 Dec;11(24 Pt 1):8763-72
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-12-15 / Clin. Cancer Res. 2005 Dec;11(24 Pt 1):8763-722005-12-15 00:00:002019-02-15 09:25:40Natural killer cells license dendritic cell cross-presentation of B lymphoma cell–associated antigens
